Next, we screened various stem cell markers and found the GBM-CSCs surface marker, CD133, to be increased in all DAB2IP-low cells, suggesting that DAB2IP might be involved in CSCs regulation in GBM (Fig. 1F, G). The gene discussed is PROM1; the disease is glioblastoma.